344 related articles for article (PubMed ID: 30481269)
21. Effect of a Russian-backbone live-attenuated influenza vaccine with an updated pandemic H1N1 strain on shedding and immunogenicity among children in The Gambia: an open-label, observational, phase 4 study.
Lindsey BB; Jagne YJ; Armitage EP; Singanayagam A; Sallah HJ; Drammeh S; Senghore E; Mohammed NI; Jeffries D; Höschler K; Tregoning JS; Meijer A; Clarke E; Dong T; Barclay W; Kampmann B; de Silva TI
Lancet Respir Med; 2019 Aug; 7(8):665-676. PubMed ID: 31235405
[TBL] [Abstract][Full Text] [Related]
22. Live Attenuated Influenza Vaccine in Children Induces B-Cell Responses in Tonsils.
Mohn KG; Brokstad KA; Pathirana RD; Bredholt G; Jul-Larsen Å; Trieu MC; Lartey SL; Montomoli E; Tøndel C; Aarstad HJ; Cox RJ
J Infect Dis; 2016 Sep; 214(5):722-31. PubMed ID: 27247344
[TBL] [Abstract][Full Text] [Related]
23. Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial.
Davidson LE; Fiorino AM; Snydman DR; Hibberd PL
Eur J Clin Nutr; 2011 Apr; 65(4):501-7. PubMed ID: 21285968
[TBL] [Abstract][Full Text] [Related]
24. An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection.
Lambkin-Williams R; Gelder C; Broughton R; Mallett CP; Gilbert AS; Mann A; He D; Oxford JS; Burt D
PLoS One; 2016; 11(12):e0163089. PubMed ID: 28005959
[TBL] [Abstract][Full Text] [Related]
25. Measuring antibody responses to a live attenuated influenza vaccine in children.
Lee MS; Mahmood K; Adhikary L; August MJ; Cordova J; Cho I; Kemble G; Reisinger K; Walker RE; Mendelman PM
Pediatr Infect Dis J; 2004 Sep; 23(9):852-6. PubMed ID: 15361726
[TBL] [Abstract][Full Text] [Related]
26. Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children.
King JC; Fast PE; Zangwill KM; Weinberg GA; Wolff M; Yan L; Newman F; Belshe RB; Kovacs A; Deville JG; Jelonek M;
Pediatr Infect Dis J; 2001 Dec; 20(12):1124-31. PubMed ID: 11740317
[TBL] [Abstract][Full Text] [Related]
27. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow-fill-seal device in adults: a randomized, active-controlled study*.
Sheldon EA; Jeanfreau R; Sliman JA; Charenkavanich S; Rousculp MD; Dubovsky F; Mallory RM
Influenza Other Respir Viruses; 2013 Nov; 7(6):1142-50. PubMed ID: 23061976
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children.
Block SL; Falloon J; Hirschfield JA; Krilov LR; Dubovsky F; Yi T; Belshe RB
Pediatr Infect Dis J; 2012 Jul; 31(7):745-51. PubMed ID: 22466322
[TBL] [Abstract][Full Text] [Related]
30. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
[TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination.
Manenti A; Tete SM; Mohn KG; Jul-Larsen Å; Gianchecchi E; Montomoli E; Brokstad KA; Cox RJ
Vaccine; 2017 Jan; 35(1):191-198. PubMed ID: 27789145
[TBL] [Abstract][Full Text] [Related]
32. Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine.
Rudenko L; Kiseleva I; Naykhin AN; Erofeeva M; Stukova M; Donina S; Petukhova G; Pisareva M; Krivitskaya V; Grudinin M; Buzitskaya Z; Isakova-Sivak I; Kuznetsova S; Larionova N; Desheva J; Dubrovina I; Nikiforova A; Victor JC; Neuzil K; Flores J; Tsvetnitsky V; Kiselev O
PLoS One; 2014; 9(2):e87962. PubMed ID: 24533064
[TBL] [Abstract][Full Text] [Related]
33. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.
Heldens J; Hulskotte E; Voeten T; Breedveld B; Verweij P; van Duijnhoven W; Rudenko L; van Damme P; van den Bosch H
Vaccine; 2014 Sep; 32(39):5118-24. PubMed ID: 24858566
[TBL] [Abstract][Full Text] [Related]
34. Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season.
King JP; McLean HQ; Meece JK; Levine MZ; Spencer SM; Flannery B; Belongia EA
Vaccine; 2018 Feb; 36(9):1214-1219. PubMed ID: 29395525
[TBL] [Abstract][Full Text] [Related]
35. Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women.
Brady RC; Jackson LA; Frey SE; Shane AL; Walter EB; Swamy GK; Schlaudecker EP; Szefer E; Wolff M; McNeal MM; Bernstein DI; Steinhoff MC
Vaccine; 2018 Jul; 36(31):4663-4671. PubMed ID: 29961606
[TBL] [Abstract][Full Text] [Related]
36. Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children.
Mohn KG; Brokstad KA; Islam S; Oftung F; Tøndel C; Aarstad HJ; Cox RJ
J Infect Dis; 2020 Apr; 221(9):1528-1537. PubMed ID: 32255493
[TBL] [Abstract][Full Text] [Related]
37. Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults.
Carter NJ; Curran MP
Drugs; 2011 Aug; 71(12):1591-622. PubMed ID: 21861544
[TBL] [Abstract][Full Text] [Related]
38. Safety of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled clinical trial among children in urban Bangladesh.
Ortiz JR; Goswami D; Lewis KD; Sharmeen AT; Ahmed M; Rahman M; Rahman MZ; Feser J; Neuzil KM; Brooks WA
Vaccine; 2015 Jun; 33(29):3415-21. PubMed ID: 25917680
[TBL] [Abstract][Full Text] [Related]
39. Activation and Induction of Antigen-Specific T Follicular Helper Cells Play a Critical Role in Live-Attenuated Influenza Vaccine-Induced Human Mucosal Anti-influenza Antibody Response.
Aljurayyan A; Puksuriwong S; Ahmed M; Sharma R; Krishnan M; Sood S; Davies K; Rajashekar D; Leong S; McNamara PS; Gordon S; Zhang Q
J Virol; 2018 Jun; 92(11):. PubMed ID: 29563292
[TBL] [Abstract][Full Text] [Related]
40. Functional immune response to influenza H1N1 in children and adults after live attenuated influenza virus vaccination.
Islam S; Zhou F; Lartey S; Mohn KGI; Krammer F; Cox RJ; Brokstad KA
Scand J Immunol; 2019 Oct; 90(4):e12801. PubMed ID: 31269273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
